Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pharmatech Associates, a regulatory compliance consultancy serving companies in the pharmaceutical, biotech and medical device industries, will lead training sessions on Quality by Design (QbD) and the new Process Validation (PV) requirements at the ...
read more
Wednesday, August 28, 2013
Pharmaceutical contract manufacturer, Sanico NV, has increased tablet inspection at its Turnhout facility in Belgium to 100% with the installation of four INSIGHT PH metal detectors from Lock Inspection Systems. The investment is part of the company...
read more
Wednesday, August 28, 2013
va-Q-tec responds to growing customer demand for va-Q-tainer containers by increasing their advanced passive pallet shipper fleet
read more
Thursday, August 29, 2013
International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the ...
read more
Thursday, August 29, 2013
Packaging Coordinators Inc (PCI) is pleased to announce that Peter Belden has assumed the role of General Manager for its Rockford, IL based facilities. PCI operates nine facilities in Rockford, totaling over 1,000,000 square feet and employing over...
read more
Thursday, August 29, 2013
Amgen and Onyx Pharmaceuticals, Inc. today announced that their Boards of Directors have unanimously approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 ...
read more
Thursday, August 29, 2013
Role to oversee a Group wide services of IT, M&A process planning, health and safety, and internal audit system.
read more
Thursday, September 05, 2013
In a dual announcement Almac Discovery Ltd and Queen’s University, Belfast (QUB) have revealed the launch of a formal working partnership between Almac and the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s, and a significant ...
read more
Thursday, September 05, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will be hosting a complimentary seminar on “Robustness, Reproducibility and Risk Management; the Route to Successful...
read more
Thursday, September 05, 2013
Capsugel and Bend Research announced today that they have entered into a definitive agreement for Capsugel to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The acquisition provides Capsugel DFS an industry leading ...
read more
Thursday, September 05, 2013
Merck, known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines ...
read more
Friday, September 06, 2013
Theorem Clinical Research has announced the addition of Ximedica, a medical product development firm, to its roster of strategic alliances.
read more
Friday, September 06, 2013
Micromeritics Instrument Corporation is proud to announce its national accreditation as a Post-Secondary Avocational/Professional Development Institution by the Accrediting Council for Continuing Education and Training (ACCET), an accrediting agency ...
read more
Tuesday, September 10, 2013
Theorem Clinical Research has promoted veteran U.K. researcher Phil Lake to head its biopharmaceutical franchise in respiratory. As executive director of biopharmaceutical development, respiratory, Lake will be responsible for senior oversight on ...
read more
Tuesday, September 10, 2013
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it is the first global CRO to implement the Clinical Research Monitor Accreditation program, ...
read more